{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T16:12:46Z","timestamp":1782749566814,"version":"3.54.5"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T00:00:00Z","timestamp":1657238400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004600","name":"Kyungpook National University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004600","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Presently, human papillomavirus (HPV)-based cervical cancer screening is commonly used and is replacing conventional cytology screening tests. The HPV genotyping assay is useful for triage in cervical cancer screening and the evaluation of HPV vaccination effects. In this study, we evaluated the clinical performance of two HPV genotyping assays, BD Onclarity HPV (Onclarity) and Seegene Anyplex II HPV28 (Anyplex) in the detection of relevant cervical lesions and for HPV genotyping concordance. Anyplex and Onclarity assays were performed on 920 consecutive liquid-based specimens. Anyplex, sensitivity, specificity, and genotyping concordance with Onclarity were optimal when restricted to \u22652+ (medium) viral loads. HPV genotyping agreement between the two assays ranged between 0.75 and 0.9 (excellent), except for HPV 33\/58, which was 0.73 (good). With Onclarity as a reference, the relative sensitivity of Anyplex for the detection of \u2265CIN 2 was 1.05 (95% CI: 0.99\u20131.1) and the relative specificity for detection of negative for intraepithelial lesion and malignancy (NILM) was 0.89 (95% CI: 0.85\u20130.93). For most \u2265CIN 2 lesions, high-risk HPV was detected by Onclarity (66\/72) and Anyplex (69\/72) assays. For high-risk HPV negative \u2265CIN 2 lesions, possible high-risk HPV genotypes were detected by Anyplex. In conclusion, the genotyping agreement between the tests was good to excellent. Full genotyping with Anyplex might confer additional benefits to patients with \u2265CIN 2, although the difference is small. We also suggest an optimal cutoff value when reporting HPV infections using the Anyplex assay (\u22652+; medium viral loads).<\/jats:p>","DOI":"10.1371\/journal.pone.0267836","type":"journal-article","created":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T17:40:36Z","timestamp":1657302036000},"page":"e0267836","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["Comparison of Seegene Anyplex II HPV28 assay with BD Onclarity HPV assay for human papillomavirus genotyping"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5804-8790","authenticated-orcid":true,"given":"Moonsik","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora Jee-Young","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7571-1064","authenticated-orcid":true,"given":"Ji Young","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,7,8]]},"reference":[{"issue":"6","key":"pone.0267836.ref001","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer","volume":"348","author":"N Mu\u00f1oz","year":"2003","journal-title":"New England journal of medicine"},{"issue":"D1","key":"pone.0267836.ref002","doi-asserted-by":"crossref","first-page":"D499","DOI":"10.1093\/nar\/gkw879","article-title":"The Papillomavirus Episteme: a major update to the papillomavirus sequence database","volume":"45","author":"K Van Doorslaer","year":"2017","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"pone.0267836.ref003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CMR.16.1.1-17.2003","article-title":"Human papillomavirus and cervical cancer","volume":"16","author":"EM Burd","year":"2003","journal-title":"Clin Microbiol Rev"},{"key":"pone.0267836.ref004","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.pvr.2018.10.001","article-title":"Single type infection of human papillomavirus as a cause for high-grade cervical intraepithelial neoplasia and invasive cancer in Japan.","volume":"6","author":"J Sakamoto","year":"2018","journal-title":"Papillomavirus Research"},{"issue":"11","key":"pone.0267836.ref005","doi-asserted-by":"crossref","first-page":"e0187844","DOI":"10.1371\/journal.pone.0187844","article-title":"HPV genotypes co-infections associated with cervical carcinoma: Special focus on phylogenetically related and non-vaccine targeted genotypes.","volume":"12","author":"R Senapati","year":"2017","journal-title":"PLoS One"},{"issue":"9686","key":"pone.0267836.ref006","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(09)61248-4","article-title":"Efficacy of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women.","volume":"374","author":"J Paavonen","year":"2009","journal-title":"The Lancet"},{"issue":"8","key":"pone.0267836.ref007","first-page":"CD008587","article-title":"Cytology versus HPV testing for cervical cancer screening in the general population","volume":"8","author":"G Koliopoulos","year":"2017","journal-title":"The Cochrane database of systematic reviews"},{"issue":"9","key":"pone.0267836.ref008","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S1470-2045(11)70188-7","article-title":"Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.","volume":"12","author":"PE Castle","year":"2011","journal-title":"Lancet Oncol."},{"issue":"1","key":"pone.0267836.ref009","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ygyno.2005.05.030","article-title":"Performance of the Roche AMPLICOR human papillomavirus (HPV) test in prediction of cervical intraepithelial neoplasia (CIN) in women with abnormal PAP smear.","volume":"99","author":"J Monsonego","year":"2005","journal-title":"Gynecol Oncol"},{"issue":"Suppl 5","key":"pone.0267836.ref010","doi-asserted-by":"crossref","first-page":"F100","DOI":"10.1016\/j.vaccine.2012.04.105","article-title":"Nucleic acid tests for the detection of alpha human papillomaviruses","volume":"30","author":"M Poljak","year":"2012","journal-title":"Vaccine"},{"issue":"8","key":"pone.0267836.ref011","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1128\/JCM.00422-11","article-title":"Evaluation of a New DNA Test for Detection of Carcinogenic Human Papillomavirus","volume":"49","author":"PE Castle","year":"2011","journal-title":"Journal of Clinical Microbiology"},{"issue":"1","key":"pone.0267836.ref012","doi-asserted-by":"crossref","first-page":"e0210997","DOI":"10.1371\/journal.pone.0210997","article-title":"Clinical performance of Anyplex II HPV28 by human papillomavirus type and viral load in a referral population.","volume":"14","author":"I Baasland","year":"2019","journal-title":"PLoS One"},{"issue":"2","key":"pone.0267836.ref013","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01518-19","article-title":"Clinical and Analytical Performance of the BD Onclarity HPV Assay with SurePath Screening Samples from the Danish Cervical Screening Program Using the VALGENT Framework","volume":"58","author":"JH Bonde","year":"2020","journal-title":"J Clin Microbiol"},{"key":"pone.0267836.ref014","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.pvr.2016.01.003","article-title":"Clinical and analytical performance of the BD Onclarity HPV assay for detection of CIN2+ lesions on SurePath samples.","volume":"2","author":"DM Ejegod","year":"2016","journal-title":"Papillomavirus Res."},{"issue":"2","key":"pone.0267836.ref015","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1128\/JCM.02749-13","article-title":"Comparison of Seegene Anyplex II HPV28 with the PGMY-CHUV assay for human papillomavirus genotyping","volume":"52","author":"C Estrade","year":"2014","journal-title":"J Clin Microbiol"},{"issue":"3","key":"pone.0267836.ref016","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.diagmicrobio.2016.04.011","article-title":"Analytical performance evaluation of Anyplex II HPV28 and Euroarray HPV for genotyping of cervical samples","volume":"85","author":"A Latsuzbaia","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"1","key":"pone.0267836.ref017","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.diagmicrobio.2016.08.022","article-title":"Comparison of Cobas\u00ae HPV and Anyplex\u2122 II HPV28 assays for detecting and genotyping human papillomavirus","volume":"87","author":"C Pasquier","year":"2017","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"16","key":"pone.0267836.ref018","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","article-title":"The 2001 Bethesda System: terminology for reporting results of cervical cytology","volume":"287","author":"D Solomon","year":"2002","journal-title":"JAMA"},{"issue":"9","key":"pone.0267836.ref019","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1128\/JCM.00508-16","article-title":"The BD Onclarity HPV Assay on Samples Collected in SurePath Medium Meets the International Guidelines for Human Papillomavirus Test Requirements for Cervical Screening","volume":"54","author":"D Ejegod","year":"2016","journal-title":"J Clin Microbiol"},{"issue":"5 Suppl 1","key":"pone.0267836.ref020","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/LGT.0b013e318287d329","article-title":"2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors","volume":"17","author":"LS Massad","year":"2013","journal-title":"J Low Genit Tract Dis"},{"issue":"3","key":"pone.0267836.ref021","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/ijc.24010","article-title":"Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older","volume":"124","author":"CJ Meijer","year":"2009","journal-title":"International journal of cancer"},{"issue":"7","key":"pone.0267836.ref022","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1158\/1055-9965.EPI-13-0053","article-title":"Age-specific occurrence of HPV16- and HPV18-related cervical cancer","volume":"22","author":"S de Sanjose","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"13","key":"pone.0267836.ref023","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1158\/1078-0432.CCR-04-2599","article-title":"Spontaneous regression of high-grade cervical dysplasia: effects of human papillomavirus type and HLA phenotype","volume":"11","author":"CL Trimble","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"3","key":"pone.0267836.ref024","doi-asserted-by":"crossref","first-page":"264.e1","DOI":"10.1016\/j.ajog.2016.10.042","article-title":"Management of women with human papillomavirus persistence: long-term follow-up of a randomized clinical trial.","volume":"216","author":"K Elfgren","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"pone.0267836.ref025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/LGT.0000000000000494","article-title":"Clinical Utility of Human Papillomavirus Genotyping in Cervical Cancer Screening: A Systematic Review.","volume":"24","author":"JH Bonde","year":"2020","journal-title":"J Low Genit Tract Dis"},{"issue":"6","key":"pone.0267836.ref026","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1055\/s-0032-1314959","article-title":"Importance of HPV Genotyping for the Screening, Therapy and Management of Cervical Neoplasias.","volume":"72","author":"M Jentschke","year":"2012","journal-title":"Geburtshilfe Frauenheilkd."},{"issue":"1","key":"pone.0267836.ref027","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12885-018-4033-2","article-title":"Prevalence of high-risk HPV genotypes, categorised by their quadrivalent and nine-valent HPV vaccination coverage, and the genotype association with high-grade lesions","volume":"18","author":"M Paz-Zulueta","year":"2018","journal-title":"BMC cancer"},{"issue":"5","key":"pone.0267836.ref028","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1159\/000506725","article-title":"HPV Genotype Prevalence and Success of Vaccination to Prevent Cervical Cancer.","volume":"64","author":"KRM Leite","year":"2020","journal-title":"Acta Cytologica"},{"issue":"5","key":"pone.0267836.ref029","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.3390\/ijerph17051726","article-title":"Utility of Human Papillomavirus Testing for Cervical Cancer Screening in Korea.","volume":"17","author":"MS Kim","year":"2020","journal-title":"International Journal of Environmental Research and Public Health"},{"issue":"2","key":"pone.0267836.ref030","doi-asserted-by":"crossref","first-page":"104","DOI":"10.15430\/JCP.2016.21.2.104","article-title":"Human Papillomavirus Prevalence and Type Distribution Among 968 Women in South Korea.","volume":"21","author":"KA So","year":"2016","journal-title":"J Cancer Prev"},{"issue":"5","key":"pone.0267836.ref031","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3343\/alm.2017.37.5.426","article-title":"Human Papillomavirus Genotype Distribution Among 18,815 Women in 13 Korean Cities and Relationship With Cervical Cytology Findings.","volume":"37","author":"EH Nah","year":"2017","journal-title":"Ann Lab Med."},{"issue":"1","key":"pone.0267836.ref032","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.3802\/jgo.2018.29.e14","article-title":"Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of Korea, 2014\u20132016","volume":"29","author":"YT Ouh","year":"2018","journal-title":"J Gynecol Oncol"},{"key":"pone.0267836.ref033","first-page":"241","volume-title":"Health seeking behaviour: doctor shopping. Primary Care Revisited","author":"F Ng","year":"2020"},{"issue":"11","key":"pone.0267836.ref034","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.3346\/jkms.2011.26.11.1461","article-title":"Overlapping medication associated with healthcare switching among Korean elderly diabetic patients","volume":"26","author":"JY Shin","year":"2011","journal-title":"Journal of Korean medical science"},{"issue":"2","key":"pone.0267836.ref035","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jhin.2016.10.008","article-title":"Middle East respiratory syndrome coronavirus (MERS-CoV) outbreak in South Korea, 2015: epidemiology, characteristics and public health implications.","volume":"95","author":"K Kim","year":"2017","journal-title":"Journal of Hospital Infection"},{"key":"pone.0267836.ref036","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jcv.2018.09.012","article-title":"The Valgent4 protocol: Robust analytical and clinical validation of 11 HPV assays with genotyping on cervical samples collected in SurePath medium.","volume":"108","author":"J Bonde","year":"2018","journal-title":"J Clin Virol"},{"key":"pone.0267836.ref037","first-page":"114435","article-title":"Concordance of Anyplex\u2122 II HPV HR assays with reference HPV assays in cervical cancer screening: systematic review","author":"H. Biazin","year":"2021","journal-title":"Journal of Virological Methods"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0267836","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T17:41:12Z","timestamp":1657302072000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0267836"}},"subtitle":[],"editor":[{"given":"Patrick","family":"Ha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,7,8]]},"references-count":37,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0267836","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,8]]}}}